Actively Recruiting
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Led by University of Chicago · Updated on 2025-05-14
4000
Participants Needed
1
Research Sites
1317 weeks
Total Duration
On this page
Sponsors
U
University of Chicago
Lead Sponsor
I
Idiopathic Pulmonary Fibrosis Clinical Research Network
Collaborating Sponsor
AI-Summary
What this Trial Is About
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
CONDITIONS
Official Title
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Interstitial lung disease
You will not qualify if you...
- Does not have Interstitial lung disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
V
Vanita Patel, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here